Quotes 5-day view Delayed Nasdaq
01/26/2023
01/27/2023
01/30/2023
01/31/2023
02/01/2023
Date
48.03(c)
48.65(c)
45.37(c)
46.83(c)
47.59(c)
Last
880 394
696 676
909 500
623 477
824 527
Volume
+4.41%
+1.29%
-6.74%
+3.22%
+1.62%
Change
Estimated financial data (e) (USD)
Sales 2022
508 M
-
-
Net income 2022
-184 M
-
-
Net cash position 2022
200 M
-
-
P/E ratio 2022
-29,2x
Yield 2022
-
Sales 2023
614 M
-
-
Net income 2023
-137 M
-
-
Net cash position 2023
148 M
-
-
P/E ratio 2023
-41,2x
Yield 2023
-
Capitalization
5 447 M
5 447 M
-
EV / Sales 2022
10,3x
EV / Sales 2023
8,63x
Nbr of Employees
1 239
Free-Float
79,3%
10x Genomics, Inc. is a life science technology company. The Company's integrated solutions include instruments, consumables, and software for analyzing biological systems. Its products include Chromium Single Cell Gene Expression, Single Cell Immune Profiling, Single Cell assay for transposase accessible chromatin (ATAC) + Gene Expression, Single Cell ATAC, Spatial Gene Expression, Spatial Gene Expression, Spatial...
Ratings of 10x Genomics, Inc.
All news about 10X GENOMICS, INC.
News in other languages on 10X GENOMICS, INC.
Analyst Recommendations on 10X GENOMICS, INC.
ETFs positioned on 10X GENOMICS, INC. ETFs and Trackers with Trackinsight
Duration :
Auto.
2 months
3 months
6 months
9 months
1 year
2 years
5 years
10 years
Max.
Period :
Day
Week
Technical analysis trends 10X GENOMICS, INC.
Short Term Mid-Term Long Term Trends Bullish Bullish Neutral
Income Statement Evolution
Please enable JavaScript in your browser's settings to use dynamic charts.
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
47,59 $
Average target price
49,67 $
Spread / Average Target
4,36%
Please enable JavaScript in your browser's settings to use dynamic charts.